NEWS 03/02/1993
NOTE TO CORRESPONDENTS Brad Stone March 2, 1993 (202) 205-4144 FDA TO HOLD PUBLIC MEETING ON BUTYLATED HYDROXYANISOLE (BHA) FDA today announced that it will hold a public meeting on April 15, 1993, to solicit scientific data and information on the food ingredient butylated hydroxyanisole (BHA). The meeting is being organized for FDA by the Federation of American Societies for Experimental Biology (FASEB) and will be held at FASEB offices, 9650 Rockville Pike, Bethesda, Md. Information presented at the meeting will be used by FASEB to prepare a report for FDA on the safety of BHA. Questions about the safety of BHA have arisen, in part, from some studies that indicated an association between BHA and cancer in two animal species. FDA has asked FASEB to reexamine all available data on the safety of BHA and evaluate whether these animal studies are relevant to the occurrence of cancer in humans. For further information contact: Sue Ann Anderson or Elwood O. Titus, Life Sciences Research Office, Federal of American Societies for Experimental Biology, 9650 Rockville Pike, Bethesda, Md. 20814, (301) 530-7030; or Office of Policy, Planning and Strategic Initiatives, Food and Drug Administration, 200 C St., S.W., Washington, D.C. 20204, (202) 205-8753. ###